Meanwhile, ER+ breast cancer cells can also produce EVs loaded with miR-19a, and promote osteolytic bone metastasis by inhibiting PTEN expression and inducing NF-κB and AKT pathways (41). The gene discussed is AKT1; the disease is breast cancer.